Skip to main content

ACE · Ascelia Pharma AB · Financials

0.8020 SEK -0.0180 (-2.20%) At close · Oct 6
Market Cap
103.89M SEK
Shares
133.54M

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Browse captured authority reports and their original financial labels

Revenue
0
FY2025 Revenue FY2020–FY2025
Net Income
-76.25M +4.7%
FY2025 Net Income FY2020–FY2025
Operating Cash Flow
-72.25M -15%
FY2025 Operating Cash Flow FY2020–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020
SEK 0 0 0 0 0 0
SEK 0 0 0 0 0 0
SEK 56.82M 50.8M 81.27M 118.11M 107.57M 64.76M
SEK 17.31M 18M 19.77M 14.63M 17.12M 18.3M
SEK -74.37M -67.77M -110.91M -147.01M -137.95M -93.43M
SEK 5.51M 13.94M 2.42M 3.97M 2.01M 18.12M
SEK -76.72M -80.12M -109.61M -133.16M -129.52M -99.75M
SEK -468K -94K -319K -1.93M -3.62M -1.05M
SEK -76.25M -80.03M -109.29M -131.22M -125.9M -98.7M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Current lease liabilities 2025-12-31 SEK 898,000 ESEF Annual Report filed 2026-04-09
Noncurrent lease liabilities 2025-12-31 SEK 72,000 ESEF Annual Report filed 2026-04-09
Short-term borrowings 2025-12-31 SEK 0 ESEF Annual Report filed 2026-04-09
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.